Surgical Site Infection by Methicillin Resistant Staphylococcus aureus- on Decline?

Susmita Bhattacharya1, Kuhu Pal2, Sonia Jain3

  • 1Professor, Department of Microbiology, NRS Medical College , Kolkata, West Bengal, India .

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of surgical site infections (SSIs). This study found MRSA prevalence and identified linezolid and tigecycline as effective treatments, highlighting the need for ongoing surveillance.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Surgical Site Infections (SSIs) are a major healthcare-associated infection.
  • Staphylococcus aureus, particularly Methicillin-Resistant Staphylococcus aureus (MRSA), is a common cause of SSIs.
  • Effective antibiotic prophylaxis is crucial for preventing SSIs.

Purpose of the Study:

  • To determine the prevalence of SSIs caused by MRSA.
  • To analyze the antibiotic sensitivity patterns of MRSA strains.

Main Methods:

  • A 3.5-year cross-sectional study involving 19,359 surgical procedures.
  • Culture and laboratory analysis of 3003 culture-positive SSIs.
  • MRSA screening using cefoxitin disc diffusion, latex agglutination, and PCR for the mecA gene.

Main Results:

  • Staphylococcus aureus was the most common pathogen (34.93%) in SSIs.
  • MRSA accounted for 25.45% of Staphylococcus aureus isolates.
  • MRSA strains showed 100% sensitivity to linezolid and tigecycline.

Conclusions:

  • MRSA is a significant pathogen in SSIs, requiring attention due to resistance to common antibiotics.
  • Regular monitoring of MRSA is essential for effective antibiotic prophylaxis and reducing SSI incidence.